Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$443M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$224M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Walt Disney
DIS
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$356M |
| 2 |
Union Pacific
UNP
|
+$330M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$213M |
| 4 |
Automatic Data Processing
ADP
|
+$164M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$97.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 13% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USCR
2026
DELISTED
U S Concrete, Inc.
USCR
| $4.47M | ﹤0.01% |
107,992
+19,247
| +22% | +$739K |
|
|
SINA
2027
DELISTED
Sina Corp
SINA
| $4.44M | ﹤0.01% |
74,932
+3,302
| +5% | +$198K |
|
2028
Allogene Therapeutics
ALLO
$714M
| $4.42M | ﹤0.01% |
152,764
+8,637
| +6% | +$251K |
|
|
NXRT
2029
NexPoint Residential Trust
NXRT
$631M
| $4.42M | ﹤0.01% |
115,190
+5,905
| +5% | +$217K |
|
|
CHS
2030
DELISTED
Chicos FAS, Inc.
CHS
| $4.4M | ﹤0.01% |
1,031,375
+51,647
| +5% | +$286K |
|
|
DRNA
2031
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.4M | ﹤0.01% |
300,456
+17,489
| +6% | +$201K |
|
2032
SiriusPoint
SPNT
$2.66B
| $4.4M | ﹤0.01% |
423,602
+12,705
| +3% | +$135K |
|
2033
Astronics
ATRO
$4.34B
| $4.4M | ﹤0.01% |
161,215
+6,494
| +4% | +$173K |
|
|
VIA
2034
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $4.39M | ﹤0.01% |
98,453
+1,854
| +2% | +$81.1K |
|
|
FARO
2035
DELISTED
Faro Technologies
FARO
| $4.38M | ﹤0.01% |
99,629
+4,825
| +5% | +$213K |
|
|
IVC
2036
DELISTED
Invacare Corporation
IVC
| $4.37M | ﹤0.01% |
522,389
+57,385
| +12% | +$413K |
|
|
JOYY
2037
JOYY Inc
JOYY
$3.74B
| $4.37M | ﹤0.01% |
52,019
+5,359
| +11% | +$390K |
|
|
LGF.A
2038
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $4.36M | ﹤0.01% |
278,832
+41,710
| +18% | +$691K |
|
|
FTR
2039
DELISTED
Frontier Communications Corp.
FTR
| $4.36M | ﹤0.01% |
2,191,274
+336,469
| +18% | +$818K |
|
2040
Coherus Oncology
CHRS
$181M
| $4.36M | ﹤0.01% |
319,349
+16,509
| +5% | +$220K |
|
2041
MACOM Technology Solutions
MTSI
$23.7B
| $4.32M | ﹤0.01% |
258,369
+12,279
| +5% | +$214K |
|
2042
MacroGenics
MGNX
$256M
| $4.3M | ﹤0.01% |
239,140
-5,532
| -2% | -$95.6K |
|
2043
GoPro
GPRO
$106M
| $4.29M | ﹤0.01% |
659,182
-524,205
| -44% | -$2.93M |
|
2044
LG Display
LPL
$3.46B
| $4.28M | ﹤0.01% |
494,825
-1,192,027
| -71% | -$10.6M |
|
2045
Inspire Medical Systems
INSP
$1.68B
| $4.26M | ﹤0.01% |
75,078
+8,650
| +13% | +$467K |
|
|
ACOR
2046
DELISTED
Acorda Therapeutics
ACOR
| $4.26M | ﹤0.01% |
2,671
+12
| +0.5% | +$21.6K |
|
|
PSDO
2047
DELISTED
Presidio, Inc. Common Stock
PSDO
| $4.25M | ﹤0.01% |
287,243
+107,793
| +60% | +$1.65M |
|
2048
CareDx
CDNA
$2.45B
| $4.25M | ﹤0.01% |
134,681
+21,035
| +19% | +$613K |
|
|
TRST
2049
Trustco Bank Corp NY
TRST
$963M
| $4.24M | ﹤0.01% |
109,304
+4,951
| +5% | +$196K |
|
|
AMAG
2050
DELISTED
AMAG Pharmaceuticals
AMAG
| $4.24M | ﹤0.01% |
329,267
-70,411
| -18% | -$1.05M |
|
Similar funds
Charles Schwab's Q1 2019 Portfolio in Review
As of Q1 2019, Charles Schwab held 3,256 positions worth $156B, up 20% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $7.96B of net new capital in Q1 2019, opening 111 new positions and adding to 2,471 existing holdings. Its largest new stake was Fox Class A: 1,745,328 shares worth $64.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Walmart Inc, an estimated $356M trimmed.
- Charles Schwab's largest Q1 2019 buy was Fox Class A: 1,745,328 shares worth $64.1M.
- Charles Schwab added most to Coca-Cola in Q1 2019, an estimated $443M increase.
- Charles Schwab's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $356M.
- Charles Schwab fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $213M.
- Charles Schwab's ten largest holdings make up 14% of its $156B portfolio in Q1 2019.
- Charles Schwab opened 111 new positions and closed 64 in Q1 2019.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $156B.
Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.